ASU grad aims to improve diagnosis for autoimmune patients like himself (opens in new tab)

As a supervisor in the sample accessioning department at a molecular diagnostics company, Ayden Hall saw firsthand how genetic sequencing and analysis could guide cancer treatment. At the same time, he was dealing with his own health challenges, navigating a delayed diagnosis of Crohn's disease.